Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose steroid plus immunosuppressant therapy for atypical membranous nephropathy
ChiCTR-IPR-14005366Phase 4Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Sep 2014
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prednisone, cyclophosphamide and cyclosporine in membranous glomerulonephritis (MGN) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: 24-hour protein excretion. Started Sep 2014; status: recruiting.
02
Drugs
prednisonecyclophosphamidecyclosporine
03
Conditions
membranous glomerulonephritis (MGN)
Beyond the preview
Go deeper on ChiCTR-IPR-14005366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005366.